Clinical trials of Z8 were delayed due to a question about compensation to patients who might be harmed during the trials raised by Prof Ludlam, supported by all of Scotland's haemophilia doctors.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Professor Christopher Armstrong Ludlam